INFU

INFU Haircut Makes Stock More Attractive

Yesterday, InfuSystem (INFU) released their 2Q results. The market was not impressed, giving shares up to as much as a 25% haircut, with shares down below the $15/share range for a large part of the day. Based on what I heard from multiple investors, there was disappointment that INFU missed analyst estimates, but even more […]

Read More »

INFU Rallies on Lymphedema & Buyback News

Shares of InfuSystem (INFU), a health care service provider facilitating outpatient care for durable medical equipment manufacturers and health care providers, have rallied as much as 30% off Monday’s close, following two key announcements made by the company. First, on Tuesday, June 29, the company announced signing an agreement with Bio Compression Systems, Inc. to […]

Read More »

INFU With Another Acute Care Market Acquisition

This morning, InfuSystem (INFU), a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced the acquisition of OB Healthcare Corporation, a privately held, Texas-based, biomedical services company. Terms of the deal were not disclosed. This is now the second acquisition in two months of a durable medical […]

Read More »

Sidoti Initiates Coverage on Growth-Machine INFU

InfuSystem (INFU), a national healthcare service provider, has been on a tear in 2020, up over 120% YTD, and over 260% since its Covid-selloff low. Yesterday, Sidoti & Company, LLC, initiated coverage of INFU with a buy rating and $26 price target. INFU began 2020 with zero analyst coverage. They have now ended the year […]

Read More »

INFU Up Big on Covid Possibilities?

InfuSystem (INFU), a national healthcare service provider, has traded today on heavy volume with the stock up 10%. This is after the stock already ran 30%+ after their latest earnings release. INFU is in a unique position as it relates to the Covid pandemic. While their integrated therapy services (ITS) revenues were slightly harmed by […]

Read More »

InfuSystem Issues Strong 2021 Guidance

This morning InfuSystem (INFU), a company written about extensively by Breakout Investor, Aaron Warwick (see his most recent INFU article here), announced strong 2021 guidance that outpaced analyst expectations. The company guided for the following in 2021: Revenues of $107 million – $110 million (analysts estimated $106M); Adjusted EBITDA of $29 million – $30 million; Operating Cash […]

Read More »

Why I’m Fired Up About PTQQF

I first wrote about Protech Home Medical Corp (PTQQF or PTQ.V) after being introduced to the company at the LD 500 in September 2020. The company reminded me a lot of InfuSystem (INFU) when I first met them, although admittedly, INFU was a little further along by that point (December 2019). PTQQF is probably where […]

Read More »

InfuSystem Continues To Climb

InfuSystem (INFU), a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care, continues its slow-but-steady post-ER climb today. The stock has rallied 17% since its November 12 earnings release and conference call, with management providing strong forward-looking guidance for the […]

Read More »